HK Stock MarketDetailed Quotes

03681 SINOMAB BIO-B

Watchlist
  • 1.900
  • 0.0000.00%
Market Closed Apr 26 16:08 CST
2.07BMarket Cap-7723P/E (TTM)

SINOMAB BIO-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
Turnover
--1.37M
--1.37M
----
----
--25.91M
----
----
----
----
----
Operating income
1.37M
1.37M
25.91M
Cost of sales
---943K
---943K
----
----
----
----
----
----
----
----
Operating expenses
-943K
-943K
Gross profit
422K
422K
Administrative expenses
-18.19%-97.62M
-48.31%-50.2M
38.09%-82.59M
-3.01%-33.85M
-85.25%-133.4M
34.32%-32.86M
-17.01%-72.01M
---50.03M
-584.13%-61.54M
-28.66%-9M
Research and development expenses
24.93%-135.41M
18.73%-66.75M
9.41%-180.37M
8.73%-82.13M
-92.56%-199.11M
-88.18%-89.98M
51.76%-103.4M
---47.82M
-353.32%-214.34M
-45.03%-47.28M
Operating interest expense
----
-49.63%-3.2M
----
14.37%-2.14M
-140.94%-5.82M
-63.98%-2.5M
-3.34%-2.42M
---1.52M
---2.34M
----
Special items of operating profit
63.79%-3.93M
36.09%-14.37M
-138.02%-10.84M
-278.31%-22.48M
-49.06%28.52M
-31.96%12.61M
2,782.34%55.98M
--18.53M
107.99%1.94M
-160.04%-24.3M
Operating profit
13.61%-236.53M
4.63%-134.1M
3.56%-273.8M
-24.72%-140.6M
-132.99%-283.91M
-39.45%-112.74M
55.90%-121.85M
-80.84M
-242.87%-276.28M
-64.65%-80.58M
Financing cost
-32.69%-6.58M
----
---4.96M
----
----
----
----
----
----
-2.33%-3.03M
Share of profits of associates
----
----
-25.81%-5.4M
-91.31%-3.19M
-474.16%-4.29M
---1.67M
---747K
----
----
----
Earning before tax
14.45%-243.11M
6.74%-134.1M
1.40%-284.16M
-25.69%-143.79M
-135.07%-288.19M
-41.52%-114.4M
55.63%-122.6M
-80.84M
-230.44%-276.28M
-61.10%-83.61M
After-tax profit from continuing operations
14.45%-243.11M
6.74%-134.1M
1.40%-284.16M
-25.69%-143.79M
-135.07%-288.19M
-41.52%-114.4M
55.63%-122.6M
-80.84M
-230.44%-276.28M
-61.10%-83.61M
Earning after tax
14.45%-243.11M
6.74%-134.1M
1.40%-284.16M
-25.69%-143.79M
-135.07%-288.19M
-41.52%-114.4M
55.63%-122.6M
-80.84M
-230.44%-276.28M
-61.10%-83.61M
Profit attributable to shareholders
14.45%-243.11M
6.74%-134.1M
1.40%-284.16M
-25.69%-143.79M
-135.07%-288.19M
-41.52%-114.4M
55.63%-122.6M
-80.84M
-230.44%-276.28M
-74.28%-83.61M
Basic earnings per share
17.24%-0.24
13.33%-0.13
0.00%-0.29
-36.36%-0.15
-141.67%-0.29
-37.50%-0.11
63.64%-0.12
-0.08
-175.00%-0.33
-0.12
Diluted earnings per share
17.24%-0.24
13.33%-0.13
0.00%-0.29
-36.36%-0.15
-141.67%-0.29
-37.50%-0.11
63.64%-0.12
-0.08
-175.00%-0.33
-0.12
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018
Turnover --1.37M--1.37M----------25.91M--------------------
Operating income 1.37M1.37M25.91M
Cost of sales ---943K---943K--------------------------------
Operating expenses -943K-943K
Gross profit 422K422K
Administrative expenses -18.19%-97.62M-48.31%-50.2M38.09%-82.59M-3.01%-33.85M-85.25%-133.4M34.32%-32.86M-17.01%-72.01M---50.03M-584.13%-61.54M-28.66%-9M
Research and development expenses 24.93%-135.41M18.73%-66.75M9.41%-180.37M8.73%-82.13M-92.56%-199.11M-88.18%-89.98M51.76%-103.4M---47.82M-353.32%-214.34M-45.03%-47.28M
Operating interest expense -----49.63%-3.2M----14.37%-2.14M-140.94%-5.82M-63.98%-2.5M-3.34%-2.42M---1.52M---2.34M----
Special items of operating profit 63.79%-3.93M36.09%-14.37M-138.02%-10.84M-278.31%-22.48M-49.06%28.52M-31.96%12.61M2,782.34%55.98M--18.53M107.99%1.94M-160.04%-24.3M
Operating profit 13.61%-236.53M4.63%-134.1M3.56%-273.8M-24.72%-140.6M-132.99%-283.91M-39.45%-112.74M55.90%-121.85M-80.84M-242.87%-276.28M-64.65%-80.58M
Financing cost -32.69%-6.58M-------4.96M-------------------------2.33%-3.03M
Share of profits of associates ---------25.81%-5.4M-91.31%-3.19M-474.16%-4.29M---1.67M---747K------------
Earning before tax 14.45%-243.11M6.74%-134.1M1.40%-284.16M-25.69%-143.79M-135.07%-288.19M-41.52%-114.4M55.63%-122.6M-80.84M-230.44%-276.28M-61.10%-83.61M
After-tax profit from continuing operations 14.45%-243.11M6.74%-134.1M1.40%-284.16M-25.69%-143.79M-135.07%-288.19M-41.52%-114.4M55.63%-122.6M-80.84M-230.44%-276.28M-61.10%-83.61M
Earning after tax 14.45%-243.11M6.74%-134.1M1.40%-284.16M-25.69%-143.79M-135.07%-288.19M-41.52%-114.4M55.63%-122.6M-80.84M-230.44%-276.28M-61.10%-83.61M
Profit attributable to shareholders 14.45%-243.11M6.74%-134.1M1.40%-284.16M-25.69%-143.79M-135.07%-288.19M-41.52%-114.4M55.63%-122.6M-80.84M-230.44%-276.28M-74.28%-83.61M
Basic earnings per share 17.24%-0.2413.33%-0.130.00%-0.29-36.36%-0.15-141.67%-0.29-37.50%-0.1163.64%-0.12-0.08-175.00%-0.33-0.12
Diluted earnings per share 17.24%-0.2413.33%-0.130.00%-0.29-36.36%-0.15-141.67%-0.29-37.50%-0.1163.64%-0.12-0.08-175.00%-0.33-0.12
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg